There have been reported that the expression of VDR is decreased in colorectal adenocarcinoma and renal clear cell cancer and increased in breast invasive carcinoma, ovarian tumor, and thyroid papillary carcinoma [13,48–51]. Here, VDR is linked to clear cell renal carcinoma.